{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:46:39Z","timestamp":1787960799152,"version":"build-2784847793"},"reference-count":103,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pain Res."],"abstract":"<jats:p>A clinical conundrum can occur when a patient with active opioid use disorder (OUD) or at elevated risk for the condition presents with cancer and related painful symptoms. Despite earlier beliefs that cancer patients were relatively unaffected by opioid misuse, it appears that cancer patients have similar risks as the general population for OUD but are more likely to need and take opioids. Treating such patients requires an individualized approach, informed consent, and a shared decision-making model. Tools exist to help stratify patients for risk of OUD. While improved clinician education in pain control is needed, patients too need to be better informed about the risks and benefits of opioids. Patients may fear pain more than OUD, but opioids are not always the most effective pain reliever for a given patient and some patients do not tolerate or want to take opioids. The association of OUD with mental health disorders (dual diagnosis) can also complicate delivery of care as patients with mental health issues may be less adherent to treatment and may use opioids for \u201cchemical coping\u201d as much as for pain control.<\/jats:p>","DOI":"10.3389\/fpain.2021.691720","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T02:28:40Z","timestamp":1637029720000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Opioid Therapy in Cancer Patients and Survivors at Risk of Addiction, Misuse or Complex Dependency"],"prefix":"10.3389","volume":"2","author":[{"suffix":"Jr","given":"Joseph V.","family":"Pergolizzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Magnusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Christo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo Ann","family":"LeQuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Breve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailyn","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.pain.2007.08.022","article-title":"High prevalence of pain in patients with cancer in a large population-based study in the Netherlands","volume":"132","author":"van den Beuken-van Everdingen","year":"2007","journal-title":"Pain"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/annonc\/mdn419","article-title":"Prevalence of undertreatment in cancer pain. A review of published literature","volume":"19","author":"Deandrea","year":"2008","journal-title":"Ann Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.hoc.2018.01.002","article-title":"Cancer pain syndromes","volume":"32","author":"Portenoy","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1200\/JCO.2013.52.4629","article-title":"Pain in cancer survivors","volume":"32","author":"Glare","year":"2014","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"crossref","unstructured":"Cancer Treatment & Survivorship: Facts and Figures 2019-20212021","DOI":"10.1002\/9781119645214.ch34"},{"key":"B6","doi-asserted-by":"publisher","first-page":"784","DOI":"10.6004\/jnccn.2019.0034","article-title":"NCCN guidelines insights: survivorship, version 2","volume":"17","author":"Sanft","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"B7","unstructured":"SwitzerlandWorld Health OrganizationWHO's Cancer Pain Ladder for Adults Geneva1986"},{"key":"B8","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Physician"},{"key":"B9","unstructured":"National Institutes of HealthAre Cancer Patients Getting the Opioids They Need to Control Pain?2020"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e593","DOI":"10.14694\/EdBook_AM.2015.35.e593","article-title":"Cancer pain management: safe and effective use of opioids","author":"Bruera","year":"2015","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","article-title":"Update on prevalence of pain in patients with cancer: systematic review and meta-analysis","volume":"51","author":"van den Beuken-van Everdingen","year":"2016","journal-title":"J Pain Symptom Manage"},{"key":"B12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.psym.2018.01.003","article-title":"Substance use disorder among current cancer patients: rates and correlates nationally in the department of veterans affairs","volume":"59","author":"Ho","year":"2018","journal-title":"Psychosomatics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e2013605","DOI":"10.1001\/jamanetworkopen.2020.13605","article-title":"National patterns in prescription opioid use and misuse among cancer survivors in the United States","volume":"3","author":"Jairam","year":"2020","journal-title":"JAMA Network Open"},{"key":"B14","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jpain.2007.11.014","article-title":"Validation of the revised screener and opioid assessment for patients with pain (SOAPP-R)","volume":"9","author":"Butler","year":"2008","journal-title":"J Pain"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1213\/ANE.0000000000002496","article-title":"Risk factors for opioid-use disorder and overdose","volume":"125","author":"Webster","year":"2017","journal-title":"Anesth Analg"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1111\/j.1360-0443.2010.03052.x","article-title":"Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system","volume":"105","author":"Boscarino","year":"2010","journal-title":"Addiction"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/j.1526-4637.2012.01450.x","article-title":"Model to identify patients at risk for prescription opioid abuse, dependence, and misuse","volume":"13","author":"Rice","year":"2012","journal-title":"Pain Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jpsychores.2012.02.009","article-title":"Dynamic risk factors in the misuse of opioid analgesics","volume":"72","author":"Pergolizzi","year":"2012","journal-title":"J Psychosom Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1001\/jamaoncol.2020.6789","article-title":"Frequency of and factors associated with nonmedical opioid use behavior among patients with cancer receiving opioids for cancer pain","volume":"7","author":"Yennurajalingam","year":"2021","journal-title":"JAMA Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jpainsymman.2007.03.011","article-title":"What patients with cancer want to know about pain: a qualitative study","volume":"35","author":"Bender","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"B21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1365-2354.2008.00936.x","article-title":"An exploration of unmet information needs among breast cancer patients in Japan: a qualitative study","volume":"18","author":"Tsuchiya","year":"2009","journal-title":"Eur J Cancer Care"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s11606-012-2077-6","article-title":"Shared decision making: a model for clinical practice","volume":"27","author":"Elwyn","year":"2012","journal-title":"J Gen Intern Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.36076\/ppj.2017.s109","article-title":"Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse: part 1","volume":"20","author":"Kaye","year":"2017","journal-title":"Pain Physician"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13346-016-0323-x","article-title":"Application of human factors engineering (HFE) to the design of a naloxone auto-injector for the treatment of opioid emergencies","volume":"7","author":"Raffa","year":"2017","journal-title":"Drug Deliv Transl Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.36076\/ppj.2011\/14\/123","article-title":"Urine drug testing in chronic pain","volume":"14","author":"Christo","year":"2011","journal-title":"Pain Physician"},{"key":"B26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11916-020-00918-z","article-title":"Review of the current state of urine drug testing in chronic pain: still effective as a clinical tool and curbing abuse, or an arcane test?","volume":"25","author":"Chakravarthy","year":"2021","journal-title":"Curr Pain Headache Rep"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1213\/ANE.0000000000000672","article-title":"Chronic opioid use and central sleep apnea: a review of the prevalence, mechanisms, and perioperative considerations","volume":"120","author":"Correa","year":"2015","journal-title":"Anesth Analg"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1002\/cncr.28619","article-title":"Association between hypogonadism, symptom burden, and survival in male patients with advanced cancer","volume":"120","author":"Dev","year":"2014","journal-title":"Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.36076\/ppj.2011\/14\/145","article-title":"A comprehensive review of opioid-induced hyperalgesia","volume":"14","author":"Lee","year":"2011","journal-title":"Pain Physician"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3109\/00365521.2015.1054423","article-title":"Opioid-induced constipation","volume":"50","author":"Gyawali","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S1470-2045(13)70244-4","article-title":"Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis","volume":"14","author":"Mitchell","year":"2013","journal-title":"Lancet Oncol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.maturitas.2015.04.010","article-title":"The prevalence of long-term symptoms of depression and anxiety after breast cancer treatment: a systematic review","volume":"82","author":"Maass","year":"2015","journal-title":"Maturitas"},{"key":"B33","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1200\/EDBK_180469","article-title":"Pain and opioids in cancer care: benefits, risks, and alternatives","volume":"37","author":"Bennett","year":"2017","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2013United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"B35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/1073110520935335","article-title":"Opioids may be appropriate for chronic pain","volume":"48","author":"Christo","year":"2020","journal-title":"J Law Med Ethics"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s12325-019-00954-1","article-title":"Three years down the road: the aftermath of the CDC guideline for prescribing opioids for chronic pain","volume":"36","author":"Pergolizzi","year":"2019","journal-title":"Adv Ther"},{"key":"B37","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1634\/theoncologist.2014-0276","article-title":"How well do medical oncologists manage chronic cancer pain? A national survey","volume":"20","author":"Breuer","year":"2015","journal-title":"Oncologist"},{"key":"B38","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1200\/JCO.2011.35.0561","article-title":"Medical oncologists' attitudes and practice in cancer pain management: a national survey","volume":"29","author":"Breuer","year":"2011","journal-title":"J Clin Oncol"},{"key":"B39","volume-title":"Prescription of Controlled Substances: Benefits and Risks","author":"Preuss","year":"2021"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/j.1476-5381.2011.01335.x","article-title":"Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human","volume":"164","author":"Morgan","year":"2011","journal-title":"Br J Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/01.ajp.0000176360.94644.41","article-title":"Analgesic addiction and pseudoaddiction in painful chronic illness","volume":"22","author":"Lusher","year":"2006","journal-title":"Clin J Pain"},{"key":"B42","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.neuroscience.2016.06.029","article-title":"Opioid-induced hyperalgesia: cellular and molecular mechanisms","volume":"338","author":"Roeckel","year":"2016","journal-title":"Neuroscience"},{"key":"B43","unstructured":"Atlanta, GeorgiaCDCPocket Guide: Tapering Opioids for Chronic Pain2018"},{"key":"B44","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3389\/fnins.2020.00569","article-title":"One is not enough: understanding and modeling polysubstance use","volume":"14","author":"Crummy","year":"2020","journal-title":"Front Neurosci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/SPC.0000000000000333","article-title":"Opioid addiction, diversion, and abuse in chronic and cancer pain","volume":"12","author":"Kata","year":"2018","journal-title":"Curr Opin Support Palliat Care"},{"key":"B46","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/01.COT.0000303168.96079.1f","article-title":"Helping cancer patients who are drug addicts receive adequate pain management","volume":"28","author":"Carlson","year":"2006","journal-title":"Oncol Times"},{"key":"B47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5055\/jom.2020.0557","article-title":"Successful use of buprenorphine-naloxone medication-assisted program to treat concurrent pain and opioid addiction after cancer therapy","volume":"16","author":"Moryl","year":"2020","journal-title":"J Opioid Manag"},{"key":"B48","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1080\/08897077.2019.1572050","article-title":"The problem of pain: additive analgesic effect of tramadol and buprenorphine in a patient with opioid use disorder","volume":"40","author":"Montalvo","year":"2019","journal-title":"Subst Abus"},{"key":"B49","first-page":"381","article-title":"Current aproach to cancer pain management: availability and implications of different treatment options","volume":"3","author":"Nersesyan","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"B50","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1196\/annals.1414.034","article-title":"Interventional pain treatments for cancer pain","volume":"1138","author":"Christo","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/ADM.0b013e318231de51","article-title":"Acute care hospital utilization among medical inpatients discharged with a substance use disorder diagnosis","volume":"6","author":"Walley","year":"2012","journal-title":"J Addict Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jsat.2013.02.009","article-title":"Medicaid care management: description of high-cost addictions treatment clients","volume":"45","author":"Neighbors","year":"2013","journal-title":"J Subst Abuse Treat"},{"key":"B53","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1521-0391.2011.00207.x","article-title":"Prevalence of unhealthy substance use on teaching and hospitalist medical services: implications for education","volume":"21","author":"Holt","year":"2012","journal-title":"Am J Addict"},{"key":"B54","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S0306-4603(01)00263-5","article-title":"Substance use in the general hospital","volume":"28","author":"Kouimtsidis","year":"2003","journal-title":"Addict Behav"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1503\/cmaj.160290","article-title":"Caring for patients with opioid use disorder in the hospital","volume":"188","author":"Donroe","year":"2016","journal-title":"CMAJ"},{"key":"B56","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11606-002-0034-5","article-title":"Mutual mistrust in the medical care of drug users: the keys to the \u201cnarc\u201d cabinet","volume":"17","author":"Merrill","year":"2002","journal-title":"J Gen Intern Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.drugpo.2019.01.015","article-title":"\u201cLike being put on an ice floe and shoved away\u201d: a qualitative study of the impacts of opioid-related policy changes on people who take opioids","volume":"66","author":"Antoniou","year":"2019","journal-title":"Int J Drug Policy"},{"key":"B58","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/add.12788","article-title":"The role of cochrane reviews in informing international guidelines: a case study of using the grading of recommendations, assessment, development and evaluation system to develop world health organization guidelines for the psychosocially assisted pharmacological treatment of opioid dependence","volume":"110","author":"Davoli","year":"2015","journal-title":"Addiction"},{"key":"B59","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/imj.12109","article-title":"Characteristics and outcomes of discharges against medical advice among hospitalised patients","volume":"43","author":"Yong","year":"2013","journal-title":"Intern Med J"},{"key":"B60","first-page":"148","article-title":"Discharges against medical advice: a community hospital's experience","volume":"9","author":"Seaborn Moyse","year":"2004","journal-title":"Can J Rural Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF02527837","article-title":"Pain treatment in cancer patients","volume":"4","author":"Twycross","year":"1990","journal-title":"Schmerz"},{"key":"B62","doi-asserted-by":"publisher","first-page":"Es39","DOI":"10.36076\/ppj.2012\/15\/ES39","article-title":"A systematic review of randomized trials on the effectiveness of opioids for cancer pain","volume":"15","author":"Koyyalagunta","year":"2012","journal-title":"Pain Physician"},{"key":"B63","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jpainsymman.2014.05.021","article-title":"Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial","volume":"49","author":"Riley","year":"2015","journal-title":"J Pain Symptom Manage"},{"key":"B64","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s12325-012-0051-7","article-title":"Opioid rotation in clinical practice","volume":"29","author":"Nalamachu","year":"2012","journal-title":"Adv Ther"},{"key":"B65","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00520-005-0843-2","article-title":"No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients","volume":"14","author":"Riley","year":"2006","journal-title":"Support Care Cancer"},{"key":"B66","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1111\/pme.12914","article-title":"Opioid induced hyperalgesia","volume":"16","author":"Yi","year":"2015","journal-title":"Pain Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"key":"B68","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jpainsymman.2007.12.005","article-title":"Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study","volume":"35","author":"Portenoy","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"B69","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2147\/JPR.S67817","article-title":"Efficacy and safety profile of combination of tramadol-diclofenac versus tramadol-paracetamol in patients with acute musculoskeletal conditions, postoperative pain, and acute flare of osteoarthritis and rheumatoid arthritis: a phase III, 5-day open-label study","volume":"7","author":"Chandanwale","year":"2014","journal-title":"J Pain Res"},{"key":"B70","first-page":"18","article-title":"Ibuprofen plus paracetamol versus ibuprofen in acute low back pain: a randomized open label multicenter clinical study","volume":"42","author":"Ostojic","year":"2017","journal-title":"Acta Reumatol Port"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1080\/03007995.2017.1310092","article-title":"Multimodal analgesia in moderate-to-severe pain: a role for a new fixed combination of dexketoprofen and tramadol","volume":"33","author":"Varrassi","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"B72","doi-asserted-by":"publisher","first-page":"CD008943","DOI":"10.1002\/14651858.CD008943.pub2","article-title":"Combination pharmacotherapy for the treatment of neuropathic pain in adults","volume":"2012","author":"Chaparro","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"B73","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1634\/theoncologist.2016-0266","article-title":"The impact of an educational program on patient practices for safe use, storage, and disposal of opioids at a comprehensive cancer center","volume":"22","author":"de la Cruz","year":"2017","journal-title":"Oncologist"},{"key":"B74","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1136\/postgradmedj-2016-134607","article-title":"A multicentre evaluation of an opioid patient\u2013provider agreement","volume":"93","author":"Pergolizzi","year":"2017","journal-title":"Postgrad Med J"},{"key":"B75","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0885-3924(00)00109-3","article-title":"Managing addiction in advanced cancer patients: why bother?","volume":"19","author":"Passik","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1016\/j.pain.2011.09.012","article-title":"The declaration montreal: access to pain management is a fundamental human right","volume":"152","author":"Cousins","year":"2011","journal-title":"Pain"},{"key":"B77","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3322\/caac.21453","article-title":"Optimal pain management for patients with cancer in the modern era","volume":"68","author":"Scarborough","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B78","doi-asserted-by":"publisher","first-page":"167","DOI":"10.5055\/jom.2012.0113","article-title":"Cancer pain in the opioid-addicted patient: can we treat it right?","volume":"8","author":"Modesto-Lowe","year":"2012","journal-title":"J Opioid Manag"},{"key":"B79","first-page":"33","article-title":"Biologic commonalities between mental illness and addiction","volume":"16","author":"Hartwell","year":"2009","journal-title":"Prim psychiatry"},{"key":"B80","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1126\/science.aad6469","article-title":"Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap","volume":"359","author":"Gandal","year":"2018","journal-title":"Science"},{"key":"B81","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","article-title":"Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States","volume":"75","author":"Hasin","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"B82","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0749-3797(98)00017-8","article-title":"Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The adverse childhood experiences (ACE) study","volume":"14","author":"Felitti","year":"1998","journal-title":"Am J Prev Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ctrv.2016.11.004","article-title":"Depression in cancer: the many biobehavioral pathways driving tumor progression","volume":"52","author":"Bortolato","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"B84","first-page":"5","article-title":"The role of depression and neuroimmune axis in the prognosis of cancer patients","volume":"19","author":"Aldea","year":"2014","journal-title":"J BUON"},{"key":"B85","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jad.2013.01.014","article-title":"A review of lifestyle factors that contribute to important pathways associated with major depression: diet, sleep and exercise","volume":"148","author":"Lopresti","year":"2013","journal-title":"J Affect Disord"},{"key":"B86","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1097\/PSY.0b013e318235be76","article-title":"Biobehavioral factors and cancer progression: physiological pathways and mechanisms","volume":"73","author":"Lutgendorf","year":"2011","journal-title":"Psychosom Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"93","DOI":"10.31887\/DCNS.2017.19.2\/bbandelow","article-title":"Treatment of anxiety disorders","volume":"19","author":"Bandelow","year":"2017","journal-title":"Dialogues Clin Neurosci"},{"key":"B88","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/jcpt.13333","article-title":"Benzodiazepines: thinking outside the black box","volume":"46","author":"Pergolizzi","year":"2020","journal-title":"J Clin Pharm Ther"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.jpainsymman.2019.12.360","article-title":"Differences in the opioid consumption of terminally ill schizophrenic and nonschizophrenic cancer patients: analysis of secondary national population data","volume":"59","author":"Lin","year":"2020","journal-title":"J Pain Symptom Manage"},{"key":"B90","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1089\/jpm.2014.0446","article-title":"A pilot study to define chemical coping in cancer patients using the delphi method","volume":"18","author":"Kwon","year":"2015","journal-title":"J Palliat Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3390\/jcm7100354","article-title":"Addressing opioid-related chemical coping in long-term opioid therapy for chronic noncancer pain: a multicenter, observational, cross-sectional study","volume":"7","author":"Castaneda","year":"2018","journal-title":"J Clin Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1017\/S1478951513001351","article-title":"Chemical coping versus pseudoaddiction in patients with cancer pain","volume":"12","author":"Kwon","year":"2014","journal-title":"Palliat Support Care"},{"key":"B93","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s40429-015-0074-7","article-title":"Pseudoaddiction: fact or fiction? An investigation of the medical literature","volume":"2","author":"Greene","year":"2015","journal-title":"Curr Addict Rep"},{"key":"B94","doi-asserted-by":"publisher","first-page":"205","DOI":"10.5055\/jom.2016.0333","article-title":"Risk factors for opioid misuse in adolescents and young adults with focus on oncology setting","volume":"12","author":"Peck","year":"2016","journal-title":"J Opioid Manag"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/jpepsy\/jsu072","article-title":"Opioid misuse behaviors in adolescents and young adults in a hematology\/oncology setting","volume":"39","author":"Ehrentraut","year":"2014","journal-title":"J Pediatr Psychol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3238\/arztebl.2019.0405","article-title":"Mortality and medical comorbidity in the severely mentally ill","volume":"116","author":"Schneider","year":"2019","journal-title":"Dtsch Arztebl Int"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/pon.5534","article-title":"Cancer and severe mental illness: bi-directional problems and potential solutions","volume":"29","author":"Grassi","year":"2020","journal-title":"Psychooncology"},{"key":"B98","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1136\/jech-2019-212311","article-title":"Stage at diagnosis and survival in patients with cancer and a pre-existing mental illness: a meta-analysis","volume":"74","author":"Davis","year":"2020","journal-title":"J Epidemiol Community Health"},{"key":"B99","first-page":"288","article-title":"Quantifying the impact of drug-drug interactions associated with opioids","author":"Pergolizzi","year":"2011","journal-title":"Am J Manag Care"},{"key":"B100","first-page":"508","article-title":"Pain management in the geriatric population","volume":"111","author":"Borsheski","year":"2014","journal-title":"Mo Med"},{"key":"B101","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1533-2500.2008.00204.x","article-title":"Opioids and the management of chronic severe pain in the elderly: consensus statement of an international expert panel with focus on the six clinically most often used world health organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone)","volume":"8","author":"Pergolizzi","year":"2008","journal-title":"Pain Pract"},{"key":"B102","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jgo.2017.11.010","article-title":"Does my older cancer patient have cognitive impairment?","volume":"9","author":"Snaedal","year":"2018","journal-title":"J Geriatr Oncol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3233\/JAD-170375","article-title":"Pain assessment in dementia: evaluation of a point-of-care technological solution","volume":"60","author":"Atee","year":"2017","journal-title":"J Alzheimers Dis"}],"container-title":["Frontiers in Pain Research"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2021.691720\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T02:28:51Z","timestamp":1637029731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2021.691720\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":103,"alternative-id":["10.3389\/fpain.2021.691720"],"URL":"https:\/\/doi.org\/10.3389\/fpain.2021.691720","relation":{},"ISSN":["2673-561X"],"issn-type":[{"value":"2673-561X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,16]]},"article-number":"691720"}}